As geopolitical risks surrounding the U.S. and Iran escalate and the domestic stock market plunges sharply, HLB Group stocks are drawing investors' attention by showing differentiated strength.

As of 9:43 a.m. on the 24th, the KOSPI is trading at 6,842.34, down 254.55 points (3.58%) from the previous trading day, while the KOSDAQ is at 766.43, down 23.85 points (3.01%). The KOSPI has fallen back below the 7,000 mark and the KOSDAQ has also dropped to the 760 level, showing a clear contraction in investor sentiment.

Even amid this market weakness, HLB Group stocks are maintaining an overall robust trend. HLB Pharmaceutical surged 17.34% to 9,470 won, recording the highest gain within the group. HLB Life Sciences also rose 12.46% to 2,300 won, posting a double-digit gain.

HLB Therapeutics climbed 8.69% to 1,887 won and HLB Genex rose 8.63% to 1,800 won, while HLB gained 7.50% to 32,250 won. HLB Global increased 7.01% to 1,296 won and HLB Panagine went up 6.97% to 1,135 won. HLB Innovation showed strength of 3.54% at 9,060 won.

Investors are watching closely to see whether the upward trend in HLB Group stocks will continue in a market environment where volatility is expanding ahead of the weekend.

[※ This article is for reference only in making investment decisions and does not recommend buying or selling any specific stock. The responsibility for investment decisions lies with the investor.]